Skip to content

Regulation of Retinal Bloodflow Pressure

Regulation of Retinal Blood Flow in Response to an Experimental Increase in Intraocular Pressure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03398616
Enrollment
17
Registered
2018-01-12
Start date
2018-03-29
Completion date
2018-12-31
Last updated
2019-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Bloodflow

Keywords

Retinal Bloodflow Pressure

Brief summary

Autoregulation is defined as the ability of a vascular bed to adapt its vascular resistance to changes in perfusion pressure. In the eye, several studies have reported that retinal blood flow is autoregulated over a wide range of ocular perfusion pressures. Large scale studies have shown that reduced ocular perfusion pressure is an important risk factor for the prevalence, the incidence and the progression of primary open angle glaucoma. There is also evidence that autoregulation is impaired in patients with primary open angle glaucoma. To gain more insight into these phenomena in humans is the primary goal of the present study. The present study aims to investigate the pressure/flow relationship as a measure for retinal blood flow autoregulation during an experimental increase in intraocular pressure by the use of the suction cup technique. Retinal blood flow will be measured by Doppler OCT.

Interventions

None listed

Sponsors

Gerhard Garhofer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women aged between 18 and 35 years * Non-smokers * Normal findings in the medical history unless the investigator considers an abnormality to be clinically irrelevant * Normal ophthalmic findings, ametropy \< 1 Dpt.

Exclusion criteria

- Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study * Treatment in the previous 3 weeks with any drug (except contraceptives) * Symptoms of a clinically relevant illness in the 3 weeks before the first study day * Blood donation during the previous 3 weeks * Pregnancy, planned pregnancy or lactating

Design outcomes

Primary

MeasureTime frame
Retinal pressure-flow-relationship as assessed with FDOCT01.02.2018-31.12.2018

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026